Nonalcoholic Steatohepatitis Completed Phase 2 Trials for Atorvastatin (DB01076)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02633956Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)Treatment